drugset / Trial / NCT00856843

BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT00856843 ↗

Phase 3 Completed 136 enrolled Braintree Laboratories
RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the safety and efficacy of BLI800 vs an FDA approved bowel preparation before colonoscopic examination in adult subjects.

Timeline

Start
2009-02
Primary completion
2009-05
Completion
—

Outcome

Met primary endpoint

paper Successful bowel preparation was more frequent with OSS than with SF-ELS (98.4% vs 89.6%; P = .04). PMID 20646695 ↗

registry Polyethylene Glycol 3350 Based Bowel Preparation vs BLI800; p = 0.038; Difference in success rates 8.8 (95% CI 0.9 to 16.8) NCT00856843 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI800 Unknown 12 unknown Oral
Comparator Polyethylene Glycol 3350 Other / unclassified 4 unknown Oral

Indications

No indication recorded.